← Leaderboards
Richard E. Champlin
University Of Texas Md Anderson Can Ctr
$5,988,814
Attributed
$6,462,335
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.6M · FY2005–19$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$48,216,093 · 10
By mechanism
P01$46,512,001 · 6
T32$947,042 · 1
U10$483,480 · 1
U01$249,408 · 1
P30$24,162 · 1
Top collaborators
- Michael Davies2 shared
Most similar at University Of Texas Md Anderson Can Ctr
Same institution · by research overlap
- Jean-Pierre J Issa$21,637,643
- Elihu Estey$3,196,729
- William K Plunkett$8,981,153
- Sergio A. Giralt$6,224,032
- Jeffrey J Molldrem$7,910,420
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsImmuneTransplantationStem Cell TransplantHematopoieticLeukemiaClinical ResearchBusulfanNovel StrategiesAllogenicHuman Therapy EvaluationNeoplasm /Cancer ChemotherapyNeoplasm /Cancer ImmunotherapyResistanceCxcr4 GeneCytotoxicityRegimenRelapseBone Marrow TransplantationFundingGrantTranslational ResearchChronic Myelogenous LeukemiaGraft-Vs-Host Disease
Grant awards (45)
13 Stem Cell Transplantation and Cellular Therapy$18,707
P30 · FY2019 · CA · contact PI
13 Stem Cell Transplantation and Cellular Therapy$5,455
P30 · FY2019 · CA · contact PI
Research Training in Academic Medical Oncology$490,275
T32 · FY2016 · CA · contact PI
Research Training in Academic Medical Oncology$456,767
T32 · FY2015 · CA · contact PI
The Therapy of CML$3,477,908
P01 · FY2014 · CA · contact PI
Novel Strategies for Hematopoietic Transplantation for Chronic Myeloid Leukemia$304,509
P01 · FY2014 · CA · contact PI
Administration$195,813
P01 · FY2014 · CA · contact PI
The Therapy of CML$3,383,296
P01 · FY2013 · CA · contact PI
Novel Strategies for Hematopoietic Transplantation for Chronic Myeloid Leukemia$404,550
P01 · FY2013 · CA · contact PI
Administration$292,492
P01 · FY2013 · CA · contact PI
Improving the Outcomes of Stem Cell Transplantation$163,530
U10 · FY2013 · HL · contact PI
The Therapy of CML$3,537,028
P01 · FY2012 · CA · contact PI
Novel Strategies for Hematopoietic Transplantation for Chronic Myeloid Leukemia$313,927
P01 · FY2012 · CA · contact PI
Administration$201,869
P01 · FY2012 · CA · contact PI
Improving the Outcomes of Stem Cell Transplantation$163,530
U10 · FY2012 · HL · contact PI
The Therapy of CML$3,438,273
P01 · FY2011 · CA · contact PI
Hematopoietic Transplantation for AML$350,327
P01 · FY2011 · CA · contact PI
Novel Strategies for Hematopoietic Transplantation for Chronic Myeloid Leukemia$307,583
P01 · FY2011 · CA · contact PI
Administration$197,791
P01 · FY2011 · CA · contact PI
Improving the Outcomes of Stem Cell Transplantation$156,420
U10 · FY2011 · HL · contact PI
The Therapy of CML$3,596,592
P01 · FY2010 · CA · contact PI
Hematopoietic Transplantation for AML$362,737
P01 · FY2010 · CA · contact PI
Novel Strategies for Hematopoietic Transplantation for Chronic Myeloid Leukemia$317,097
P01 · FY2010 · CA · contact PI
Administration$203,908
P01 · FY2010 · CA · contact PI
Blood Marrow Transplant Clinical Trials Research Network$150,504
U01 · FY2010 · HL · contact PI
Hematopoietic Transplantation for AML$356,940
P01 · FY2009 · CA · contact PI
Blood Marrow Transplant Clinical Trials Research Network$98,904
U01 · FY2009 · HL · contact PI
Hematopoietic Transplantation for AML$354,797
P01 · FY2008 · CA · contact PI
THERAPY OF CML$3,552,240
P01 · FY2007 · CA · contact PI
Hematopoietic Transplantation for AML$351,356
P01 · FY2007 · CA · contact PI
THERAPY OF CML$3,556,156
P01 · FY2006 · CA · contact PI
THERAPY OF CML$3,538,057
P01 · FY2005 · CA
THERAPY OF CML$3,436,780
P01 · FY2004 · CA
THERAPY OF CML$2,088,460
P01 · FY2003 · CA
THERAPY OF CML$740,244
P01 · FY2003 · CA
THERAPY OF CML$2,789,679
P01 · FY2002 · CA
HEMATOPOIETIC TRANSPLANTATION FOR AML$0
P01 · FY2002 · CA
ALLOGENEIC BONE MARROW TRANSPLANTATION FOR CML$0
P01 · FY2002 · CA
THERAPY OF CML$2,715,148
P01 · FY2001 · CA
HEMATOPOIETIC TRANSPLANTATION FOR AML$0
P01 · FY2001 · CA
ALLOGENIC BLOOD AND MARROW TRANSPLANT FOR ACUTE MYELOGENOUS LEUKEMIA$0
P01 · FY2001 · CA
ALLOGENEIC BONE MARROW TRANSPLANTATION FOR CML$0
P01 · FY2001 · CA
THERAPY OF CML$1,903,897
P01 · FY2000 · CA
ALLOGENIC BLOOD AND MARROW TRANSPLANT FOR ACUTE MYELOGENOUS LEUKEMIA$163,224
P01 · FY2000 · CA
ALLOGENEIC BONE MARROW TRANSPLANTATION FOR CML$79,323
P01 · FY2000 · CA